Fernando F. Corrales‐Medina

Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial

Leonardo R. Brandão, Matteo Luciani, Lisa Bomgaars et al. · The Lancet Haematology · 2020 · 149 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +12

Prevalence of the metabolic syndrome in Peruvian Andean hispanics: The PREVENCION study

Josefina Medina‐Lezama, Humberto Zea-Díaz, Oscar L. Morey‐Vargas et al. · Diabetes Research and Clinical Practice · 2007 · 82 citations

Medicine, Endocrinology, Nutritional Sciences +14

Endogenous Nitric Oxide Synthase Inhibitors, Arterial Hemodynamics, and Subclinical Vascular Disease

Julio A. Chirinos, Robert David, J. Alexander Bralley et al. · Hypertension · 2008 · 66 citations · Full text

Medicine, Cardiology, Pharmacology +13

Theranostic profiling for actionable aberrations in advanced high risk osteosarcoma with aggressive biology reveals high molecular diversity: the human fingerprint hypothesis

Daniela Egas-Bejar, Pete Anderson, Rishi Agarwal et al. · Oncoscience · 2014 · 52 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Optimal Definitions for Abdominal Obesity and the Metabolic Syndrome in Andean Hispanics: The PREVENCION Study

Josefina Medina‐Lezama, Catherine A. Pastorius, Humberto Zea-Díaz et al. · Diabetes Care · 2010 · 48 citations · Full text

Public Health, Cardiology, Clinical Epidemiology +13